1,672 Followers on Owler

Blueprint

Medicines is a Massachusetts-based biotechnology company that develops and commercializes precision therapies for the treatment of cancer... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Blueprint

Medicines is a Massachusetts-based biotechnology company that develops and commercializes precision therapies for the treatment of cancer... Read more
Blueprint CEO: Kate Haviland

CEO

Kate Haviland

CEO Approval Rating

82/100

2011

PublicIndependent CompanyNASDAQBPMC

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Annual Revenue
$508.8M
Employees
640
Funding
$2.2B
Acquisitions
1

News

Conference Presentation
Dec 18, 2024
Marketscreener
Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Blueprint Competitors

1TP Therapeutics
2Cogent
3AB Science
4Tarveda
5Selecta
6AVEO
7Jounce
8NexImmune
9Dauntless Pharmaceuticals
10Progenics
Unlock 24 + competitors

Trending Companies